Veterinary Medicines

LIQUIBAC

Not authorised
  • COLISTIN SULFATE
Download as PDF

Product identification

Medicine name:
LIQUIBAC
Active substance:
  • COLISTIN SULFATE
Target species:
  • Pig (piglet)
  • Cattle (calf)
  • Chicken (broiler)
  • Turkey
  • Rabbit
  • Duck
  • Chicken (layer hen)
  • Guinea fowl
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • COLISTIN SULFATE
    120.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Pig (piglet)
      • Meat and offal
        7
        day
    • Cattle (calf)
      • Meat and offal
        7
        day
    • Chicken (broiler)
      • Meat and offal
        0
        day
    • Turkey
      • Meat and offal
        1
        day
    • Rabbit
      • Meat and offal
        5
        day
    • Duck
      • Meat and offal
        0
        day
    • Chicken (layer hen)
      • Egg
        0
        day
    • Guinea fowl
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA10
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Revoked
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol Italia S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol Italia S.r.l.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 102463
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 18/05/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."